In summary, the results of this study suggest that XLOC_000647 not only acts as a new tumor-inhibiting factor of lncRNA, but also may be regarded as a major adjustment factor of NLRP3, which is able to inhibit cell proliferation, invasion, and EMT of PDA. The gene discussed is NLRP3; the disease is neoplasm.